ARMEN GARO H 4

What Happened Garo H. Armen, Chairman, Chief Executive Officer and Principal Financial Officer of Agenus (AGEN), received 4,644 shares of common stock as compensation for the pay period ending May 29, 2026. The shares were issued at the closing price of $3.50 on May 29, 2026, for a total value of $16,254. The issuance was an award/stock-for-salary transaction and the shares were fully vested on the date of issuance.

Key Details

• Transaction date: May 29, 2026; Form 4 filed June 2, 2026 (filed within the normal two-business-day window).
• Transaction type/code: Award/acquisition (A) — shares issued in lieu of cash salary.
• Price/value: $3.50 per share (closing price on May 29, 2026); total value ~$16,254.
• Shares held after transaction: Not explicitly stated in the filing. Footnotes disclose related holdings: 23,950 shares in the Garo Armen 2020 2-Year AG GRAT (Dr. Armen is trustee and has investment authority) and 5,000 shares held by Pixie Partners (a partnership in which he is a general partner); shares from this issuance are held in Dr. Armen’s IRA accounts.
• Notable footnotes: (F1) salary paid in stock with Compensation Committee approval; shares fully vested on issuance. (F2) price based on closing market price. (F3) shares held in IRA. (F4) disclosures about GRAT and Pixie holdings and a disclaimer of beneficial ownership to the extent of pecuniary interest.

Context This was a compensation-issued stock award (not an open-market purchase or sale). Such stock-for-salary issuances are routine forms of executive compensation and do not by themselves indicate insider buying or selling sentiment. The filing appears timely under Form 4 rules.